MedTrace Logo

Post-sleeve Gastrectomy Gastroesophageal Reflux Disease Prediction

NCT04411823 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2026-03-05

No results posted yet for this study

Summary

Researchers are trying to identify predictors for gastroesophageal reflux disease after sleeve gastrectomy.

Conditions

  • Gastroesophageal Reflux
  • Sleeve Gastrectomy
  • Bariatric Surgery Complication

Interventions

DEVICE

EndoFLIP measurement

EndoFLIP device can measure gastroesophageal junction distensibility index and esophageal contractile pattern under FDA cleared indication. It is performed during endoscopy.

Sponsors & Collaborators

Principal Investigators

  • Omar Ghanem, MD · Mayo Clinic

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-01
Primary Completion
2028-10-31
Completion
2028-10-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04411823 on ClinicalTrials.gov